Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive staphylococcal infections

Journal of the Pediatric Infectious Diseases Society

Volumn 2, Issue 3, 2013, Pages 259-262

  Chhim, Rebecca F ^a,b   Arnold, Sandra R ^a,b   Lee, Kelley R ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

Area under the curve; Children; Methicillin resistant staphylococcus aureus; Trough concentration; Vancomycin

Indexed keywords

CREATININE; VANCOMYCIN;

AREA UNDER THE CURVE; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; DRUG CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MODERATE RENAL IMPAIRMENT; PRIORITY JOURNAL; SEVERE RENAL IMPAIRMENT; STAPHYLOCOCCUS INFECTION;

EID: 84888642447     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis083     Document Type: Article

References (12)

1. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006; 44:3883-6.
2. Dombrowski JC, Winston LG. Clinical failures of appropriatelytreated methicillin-resistant Staphylococcus aureus infections. J Infect 2008; 57:110-5.
3. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009; 28:398-402.
4. Welsh KJ, Abbott AN, Lewis EM, et al. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. J Clin Microbiol 2010; 48: 894-9.
5. Frymoyer A, Guglielmo BJ,Wilson SD, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy 2011; 31:871-6.
6. Eiland LS, English TM, Eiland EH 3rd. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother 2011; 45:582-9.
7. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
8. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004; 43:925-42.
9. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-63.
10. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317:1098.
11. Chang D. Influence of malignancy on the pharmacokinetics of vancomycin in infants and children. Pediatr Infect Dis J 1995; 14:667-73.
12. Vaudaux P,Huggler E, Bernard L, et al. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 3861-70.